Venlafaxine Hydrochloride
NDC 65862-697, Venlafaxine Hydrochloride, capsule, extended release, from Aurobindo Pharma Limited.
- Product NDC
- 65862-697
- Status
- Listed
- Labeler
- Aurobindo Pharma Limited
- Dosage form
- CAPSULE, EXTENDED RELEASE
- Route
- ORAL
- Product type
- HUMAN PRESCRIPTION DRUG
- Marketing category
- ANDA
- Application
- ANDA200834
- DEA schedule
- None
curl https://api.healthcare.dev/v1/drugs/ndc/65862-697 \ -H "Authorization: Bearer $HDEV_API_KEY"
Product
Active ingredients and packages
Active ingredients
- VENLAFAXINE HYDROCHLORIDE150 mg/1
Pharmacologic classes
Norepinephrine Uptake Inhibitors [MoA]; Serotonin Uptake Inhibitors [MoA]; Serotonin and Norepinephrine Reuptake Inhibitor [EPC]
| Package NDC | NDC-11 | Package |
|---|---|---|
| 65862-697-01 | 65862069701 | 100 CAPSULE, EXTENDED RELEASE in 1 BOTTLE (65862-697-01) |
| 65862-697-05 | 65862069705 | 500 CAPSULE, EXTENDED RELEASE in 1 BOTTLE (65862-697-05) |
| 65862-697-10 | 65862069710 | 10 BLISTER PACK in 1 CARTON (65862-697-10) / 10 CAPSULE, EXTENDED RELEASE in 1 BLISTER PACK |
| 65862-697-26 | 65862069726 | 2500 CAPSULE, EXTENDED RELEASE in 1 BOTTLE (65862-697-26) |
| 65862-697-30 | 65862069730 | 30 CAPSULE, EXTENDED RELEASE in 1 BOTTLE (65862-697-30) |
| 65862-697-47 | 65862069747 | 15 CAPSULE, EXTENDED RELEASE in 1 BOTTLE (65862-697-47) |
| 65862-697-90 | 65862069790 | 90 CAPSULE, EXTENDED RELEASE in 1 BOTTLE (65862-697-90) |
Linked data
RxNorm, label and prices
Related lookups
FDA label sections
GET /v1/drugs/labels/85d3ce8b-8966-45d9-bdaf-f6f0475096e1NADAC price for package 65862069701
GET /v1/drugs/nadac/65862069701NADAC price for package 65862069705
GET /v1/drugs/nadac/65862069705NADAC price for package 65862069730
GET /v1/drugs/nadac/65862069730NADAC price for package 65862069790
GET /v1/drugs/nadac/65862069790
Use it
Look up 65862-697 from code or an agent
curl https://api.healthcare.dev/v1/drugs/ndc/65862-697 \ -H "Authorization: Bearer $HDEV_API_KEY"
Using the healthcare.dev MCP server, look up NDC 65862-697. Tell me the product, its labeler, dosage form and route, its packages, and the RxNorm concepts it maps to.
Source: FDA, release 2026-10-23. Public domain. Reference data, not medical advice.